Rabinovich Eitan, Heyne Michael, Bakhman Anna, Kosloff Mickey, Shifman Julia M, Papo Niv
Department of Biotechnology Engineering, and the National Institute of Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Department of Biotechnology Engineering, and the National Institute of Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel; Department of Biological Chemistry, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.
J Mol Biol. 2017 Jan 6;429(1):97-114. doi: 10.1016/j.jmb.2016.11.018. Epub 2016 Nov 25.
The stem cell factor (SCF)/c-Kit receptor tyrosine kinase complex-with its significant roles in hematopoiesis and angiogenesis-is an attractive target for rational drug design. There is thus a need to map, in detail, the SCF/c-Kit interaction sites and the mechanisms that modulate this interaction. While most residues in the direct SCF/c-Kit binding interface can be identified from the existing crystal structure of the complex, other residues that affect binding through protein unfolding, intermolecular interactions, allosteric or long-distance electrostatic effects cannot be directly inferred. Here, we describe an efficient method for protein-wide epitope mapping using yeast surface display. A library of single SCF mutants that span the SCF sequence was screened for decreased affinity to soluble c-Kit. Sequencing of selected clones allowed the identification of mutations that reduce SCF binding affinity to c-Kit. Moreover, the screening of these SCF clones for binding to a structural antibody helped identify mutations that result in small or large conformational changes in SCF. Computational modeling of the experimentally identified mutations showed that these mutations reduced the binding affinity through one of the three scenarios: through SCF destabilization, through elimination of favorable SCF/c-Kit intermolecular interactions, or through allosteric changes. Eight SCF variants were expressed and purified. Experimentally measured in vitro binding affinities of these mutants to c-Kit confirmed both the yeast surface display selection results and the computational predictions. This study has thus identified the residues crucial for c-Kit/SCF binding and has demonstrated the advantages of using a combination of computational and combinatorial methods for epitope mapping.
干细胞因子(SCF)/c-Kit受体酪氨酸激酶复合物在造血和血管生成中发挥着重要作用,是合理药物设计的一个有吸引力的靶点。因此,有必要详细绘制SCF/c-Kit相互作用位点以及调节这种相互作用的机制。虽然直接的SCF/c-Kit结合界面中的大多数残基可以从该复合物的现有晶体结构中确定,但通过蛋白质解折叠、分子间相互作用、变构或长距离静电效应影响结合的其他残基无法直接推断。在这里,我们描述了一种使用酵母表面展示进行全蛋白表位作图的有效方法。筛选了一个跨越SCF序列的单个SCF突变体文库,以寻找与可溶性c-Kit亲和力降低的突变体。对选定克隆进行测序,从而鉴定出降低SCF与c-Kit结合亲和力的突变。此外,筛选这些SCF克隆与一种结构抗体的结合情况,有助于鉴定导致SCF发生小的或大的构象变化的突变。对实验鉴定的突变进行计算建模表明,这些突变通过以下三种情况之一降低了结合亲和力:通过SCF的不稳定、通过消除有利的SCF/c-Kit分子间相互作用或通过变构变化。表达并纯化了8种SCF变体。实验测量这些突变体与c-Kit的体外结合亲和力,证实了酵母表面展示选择结果和计算预测。因此,本研究确定了对c-Kit/SCF结合至关重要的残基,并证明了使用计算和组合方法相结合进行表位作图的优势。